The purpose of this investigational study is to determine if a study medication is safe and effective in reducing the symptoms associated with endometriosis; if the study medication reduces the need for pain medication for endometriosis symptoms; and if the study medication improves a participant's ability to carry out daily activities. Qualified participants will receive no cost treatment, which may include study-related examinations, diagnostic procedures including a Pap smear, laboratory testing, and a mammogram (aged 40-45). Qualified participants will also receive study medication at no cost. As a participant, the study volunteer may also experience the satisfaction of knowing she is helping the advancement of women's health care.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
200
Unnamed facility
Phoenix, Arizona, United States
Unnamed facility
Tucson, Arizona, United States
Unnamed facility
Carmichael, California, United States
Unnamed facility
La Jolla, California, United States
Unnamed facility
Redding, California, United States
Unnamed facility
To assess the effects and to compare the safety profile of an investigational
medication on the relief of endometriosis-related symptoms.
Clinical and subject assessment of symptoms related to endometriosis and the
use of analgesia to relieve symptoms.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
San Diego, California, United States
Unnamed facility
Lakewood, Colorado, United States
Unnamed facility
Aventura, Florida, United States
Unnamed facility
Boynton Beach, Florida, United States
Unnamed facility
Celebration, Florida, United States
...and 36 more locations